IDH1 and cancer: Some of these mutations (e.g., isocitrate dehydrogenase (IDH), Succinate dehydrogenase (SDH), fumarate hydratase (FH)) lead to the abnormal production of metabolites associated with cancer progression, called “oncometabolites” [11].